Guidance for Valeant Pharmaceuticals International (VRX)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2016 $5.30 – $5.50 $6.45 $9.55B – 9.65B $9.92B Lowered Details
2016 $9.50 – $10.50 $13.24 $11.00B – 11.20B $12.41B = Maintained Details
2016 $6.60 – $7.00 $8.47 $9.90B – 10.10B $10.86B Lowered Details
Q1 2016 $1.30 – $1.55 $2.63 $2.30B – 2.40B $2.82B = Maintained Details
2015 $11.50 – $11.80 N/A $10.70B – 11.10B N/A Raised Details
2015 $11.67 – $11.87 N/A N/A N/A Raised Details
Q4 2015 $4.00 – $4.20 N/A N/A N/A Raised Details
Q3 2015 $2.60 – $2.70 N/A $2.60B – 2.80B N/A = Maintained Details
2013 $5.55 – $5.85 N/A $4.40B – 4.80B N/A Raised Details
2013 $6.11 – $6.16 N/A N/A N/A = Maintained Details
2012 $4.60 – $4.65 N/A N/A N/A = Maintained Details
2012 $4.55 – $4.75 $4.51 N/A N/A = Maintained Details
2012 $4.45 – $4.70 N/A $3.40B – 3.60B N/A Raised Details
Q4 2012 $1.30 – $1.35 N/A N/A N/A = Maintained Details
2011 $2.45 – $2.70 N/A N/A N/A = Maintained Details
2011 $2.70 – $3.00 N/A N/A N/A Raised Details
2011 $2.65 – $2.90 N/A N/A N/A = Maintained Details